Ffm turkey lowres

LIFE SCIENCE TO TURKEY

Fact Finding Mission / March 28 – 31, 2017

OFFICIAL PROGRAM

PARTNER

Business Delegation Life Science to Turkey

Switzerland Global Enterprise is organizing a fact finding mission to Turkey for Swiss companies to get to know the local Life Science sector and make first steps towards a successful market entry. Don’t miss the opportunit to gain inside information and enlarge your network.

Turkey’s 80 million inhabitants have been growing accustomed to modern health care during the country’s rapid development over the last decade. ­Demand is going to rise even further in the next 20 years as the currently young population ages.

HEALTHCARE, PHARMA

The pharmaceutical market in Turkey is set to rise from $5 billion in 2015 to $5.53 billion by 2020, representing a compound annual growth rate of 2%. Accor­ ding to IMS Health Report, Turkey is one of the top 20 “pharmerging” countries, having been ranked 19th in 2014, and expected to be ranked 17th in 2019.

The Turkish market is expected to grow by 11-14 percent between 2015-2019.

Short summary of sectors

During 2009-2015, pharma sales grew by 27.8 percent and 43 multinational pharmaceutical companies entered the Turkish market, bringing the number of foreign entities in the market to 116.

Pharma exports, which stood at USD 612 million in 2010, have grown by 53.4 percent over the past five years to reach USD 939 million in 2015.

Turkish pharmaceuticals are now sold in 144 countries, which include member nations of the European Union, the Commonwealth of Independent States (CIS), North Africa, and the Middle East

Turkey has one of the largest and youngest labor pools in Europe, with more than 42 percent of the population aged between 24 and 54, and the strength of Turkey’s labor force is reflected in the pharmaceutical sector. In the 2011-2012 academic year, more than 41,000 students graduated from vocational training­ schools and universities in fields related to the pharmaceutical sector.

Short summary of sectors

MEDICAL TECHNOLOGY

Turkey has discovered a new and very lucrative revenue stream – medical tourism – but still needs to put a high level of investment to position itself as a global player. Turkey has become one of the most popular medical tourism destinations. The number of healthcare tourists visiting Turkey reached 746,000 and the revenue they brought in reached $5.8 billion in 2015. A total of 60 percent of these tourists came from the Middle East, North Africa and the Gulf region; 20 percent from Central Asian republics and the remaining 20 per­ cent from Europe and other countries. The sector expects a 15 percent rise in the number of healthcare tourists this year. The public sector plans to build hospitals in 15 cities in 2017 – giving a total capacity of 25,000 beds. “Turkey aims to increase the hospital bed capacity to 28 per 10,000 in population by 2018, and to 30 by 2023, according to Turkey’s Minister of Health, Mehmet Muezzinoglu. The investment total of the envisioned PPP projects to be realized in Turkey’s healthcare sector is expected to hit USD 200 billion by 2023. Private providers have already identified Turkey as an attractive destination for medical tourists. International companies from Malaysia, Qatar and the USA already have a presence in Turkey and are also prepared to put further investment into the area. As a result of this, attractive new business op­ portunities are set to open up for Swiss companies.

BIOTECHNOLOGY

The term biotechnology first appeared in the programs of the Scientific and Technological Research Council of Turkey (TUBITAK) in 1982. Turkey has been researching and investing in biotechnology for almost four decades. Al­ though biotechnology has been highlighted as important in the Economic de­ velopment plan, the industry is still largely in the imitation phase of wes­ tern countries with little original research being conducted. Most life science companies in Turkey are generics companies, distributors and subsidiaries of big pharmaceutical, with biotechnology playing a very limited role Further­ more, related industries are mostly focused on cost saving rather than tech­ nology development, lowering the overall level of genuine innovation in the country. Innovation and startups are the most recent economic fads in Tur­ key, as in most of the world. To the Western eye, the reasons for this success can be devoted to ‘fast product development time’, ‘new generation services’, ‘fast growth rates’, etc. However, this is Turkey, which is perched on the gate of the Orient. There are different market dynamics in this part of the world.

Competition prefers, as the UN Secretary General Ban Ki-moon stated by his last visit to Turkey, ‘know-who’, instead of know-how’. The majority of bio­ technology activity in Turkey is focused on agribio research and development.

The main revenue generating companies in Turkey are large organizations producing and researching seed and animal feed technologies.

FACT FINDING MISSION LIFE SCIENCE TO TURKEY

3

Program

MARCH 28 – 31, 2017 TUESDAY, MARCH 28, 2017

WEDNESDAY, MARCH 29, 2017

THURSDAY, MARCH 30, 2017

FRIDAY, MARCH 31, 2017

Noon Individual arrival at Istanbul Airport

Morning Intro & Program, Head of Swiss Business Hub, Mr Mehmet Yildirimli / Consul General, Ms Monika Schmutz Kirgöz

Morning Business Breakfast with only Swiss CEOs (@Mövenpick Hotel)

Morning Visit expomed (guided tour)

Transfer to Mövenpick Hotel Check-in

Evening Dinner at Bosphorus

Presentations on the Turkish IP, Patent and CE marking situations @ Bogazici Univer­ sity/ İSEK/İnovita, (Prof. Cengizhan Öztürk or Prof. Banu Onaral)

Presentation on the Future Economic Development and Strategy of the Life Sci­ ences industry in Turkey, Chief Economist TÜSIAD (Turkish Industry and Business Association), Ms Zümrüt Imamoglu

Noon Luncheon with Swiss Chamber of Com­ merce in Turkey and board members @ Swissotel (Success Stories CH companies)

Noon Lunch & Networking with: ·· Istanbul Chamber of Commerce (ITO) ·· The Istanbul Chamber of Industry (ISO) ·· Foreign Economic Relations Board (DEIK) Afternoon Group A Matchmaking with Turkish companies at ITO/ISO/DEIK

As the biggest fair in Turkey and Eurasia where medical devices, equipment and technologies are showcased and the latest medical trends and scientific events can be tracked, expomed brings together the de­ cision makers in the healthcare industry in Istanbul. In 2016 the show was visited around 33.000 professional visitors where more than 900 companies and company re­ presentatives exhibited from all over the world.

Afternoon Visit President of Investment Support and Promotion Agency for Turkey (ISPAT)

Noon Lunch@Expo

Company visit (i.e. Abdi Ibhrahim, Acibadem hospital or Dünyagöz Hospital)

Afternoon Matchmaking with Turkish companies and departure

Evening Individual Dinner

or Group B Company visit (i.e. Abdi Ibhrahim, Acibadem hospital or Dünyagöz Hospital)

Evening Dinner & VIP Networking at Swiss Consul General's Residence Intro Dogan Taskent, Technology Transfer Accelerator Advisory, TTA (Turkey Ad­ visory Services) & Secretary General of the Swiss Chamber of Commerce in Turkey

REGISTER NOW

s-ge.com/z8e9p

5

Registration Life Science Fact Finding Mission to Turkey

I WISH TO REGISTER

Participant information

LANGUAGE

English

PARTICIPATION COSTS

Included in the price: ·· Overall organization of the business trip ·· Accommmodation 3 nights in an upper class business hotel incl. breakfast, lunch and dinner ·· Local transport ·· Faciliation of top business contacts to private business and Turkish authorities

CONTACT

Not included ·· Flights to Istanbul and back ·· Transfer to hotel Price per person (excl. VAT) CHF 3'490.– Switzerland Global Enterprise gold members

SUHAIL EL OBEID Senior Consultant Africa, Middle East, Iran + Turkey selobeid@s-ge.com T +41 44 365 54 72

CHF 3'790.– Switzerland Global Enterprise silver members CHF 3'990.– Non-members

{{ CHF 3'490.– Switzerland Global Enterprise gold members

YOUR CONTACT INFORMATION

FIRST NAME LAST NAME

{{ CHF 3'790.– Switzerland Global Enterprise silver members

COMPANY POSITION

{{ CHF 3'990.– Non-members

ADDRESS

Price per person (excl. VAT). Cancellations up to 14 days prior to the travel date are charged at 50%; after that, the entire participation costs shall be invoiced. Substitute participants are welcome without any extra charge.

POSTCODE/CITY

I AM ALSO INTERESTED IN

E-MAIL

{{ Switzerland Global Enterprise membership and would like to benefit from a discount for CHF 200.– (silver members) and CHF 500.– (gold members) for this Mission. {{ Monthly newsletter export.news {{ Unfortunately, I can't take part in this business mission.

Please keep me informed about future opportunities.

TELEPHONE CELL PHONE

DATE SIGNATURE

For further questions please contact: events@s-ge.com

MEHMET YILDIRIMLI Head of Swiss Business Hub Turkey mehmet.yildirimli@eda.admin.ch T +90 212 283 12 82

Fact Finding Mission Life Science to turkey

7

ExportHelp

s-ge.com/exporthelp exporthelp@s-ge.com T +41 844 811 812

Switzerland Global Enterprise Stampfenbachstrasse 85 CH-8006 Zürich T +41 44 365 51 51 Switzerland Global Enterprise Corso Elvezia 16 - CP 5399 CH-6901 Lugano T +41 91 601 86 86 Switzerland Global Enterprise Avenue d’Ouchy 47 - CP 315 CH-1001 Lausanne T +41 21 545 94 94 s-ge.com

© SWITZERLAND GLOBAL ENTERPRISE NOVEMBER 2016. All rights reserved.